Elizabeth R Kessler

Congratulations to CU Cancer Center leader Christopher Lieu, MD, for being named as the Vice Chair of the @NCCN! Learn more about Lieu's new role here: news.cuanschutz.edu/cancer-center/…

Congratulations to Eryn Callihan @CUAnschutz presenting on patterns of chemotherapy use with trimodality therapy for muscle-invasive #bladdercancer at #GU24 - Cisplatin monotherapy most common - Over time, less taxane and more Gemzar use - Older patients more likely to get Gemzar

Check out the upcoming Cancer Neuroscience Symposium, wich will leverage advances in neuroscience, as well as advances in immuno-oncology and the biology of AGING. Feb 29-Mar 1. onlinelibrary.wiley.com/page/journal/2…

The latest issue of @AgingANDCancer is out! Great papers on Aging&AML, risks for older cancer survivors, and recommendations post gastric cancer surgery. @WileyOnc_Hem @wileyinresearch @WileyHealth @WaxmanCancer

Great to partner with @simon_p_kim @SpiessPhilippe @BourlonMaite @kesslerer Nellowe Candelario and others to highlight racial survival differences in an very understudied oncologic disease setting.

Congratulations @CathyjBradley on being named dean of @ColoradoSPH! Thrilled to see such an outstanding leader selected for this role and look forward to supporting the research momentum and growth in the school. news.cuanschutz.edu/news-stories/c…

@LauraGrahamMD Thanks @LauraGrahamMD !

@LauraGrahamMD Well deserved!

Nivolumab + ipilimumab + cabozantinib triplet combo for untreated advanced #RenalCellCarcinoma pts: Results from a discontinued arm of the phase 3 CheckMate 9ER trial ⁦@DrChoueiri⁩ ⁦@tompowles1⁩ ⁦@BurottoMauricio⁩ ⁦@motzermd⁩ #RCC sciencedirect.com/science/articl…

@MelissaLoh21 @YoungSIOG @BloodAdvances @melisawongmd @HKlepinMD @WilmotCancer @nysnorton @danielrich21 @WilliamDale_MD @tomleblancMD @Areejmd @myCARG @URMC_DeptMed Nice! Really interested to see the “will be tested in future studies”- it’s so important and meaningful!

A nice reminder of the beginnings of our spectacular medical campus

Today at #BCANTT22, BCAN announced its first-ever Translational Clinical Trial Award (TCTA) to support patient-oriented research to transform #bladdercancer - up to $3M in funding over 3 years. Click for more detailed about this exciting announcement: bcan.org/bladder-cancer…

@ERPlimackMD @ASCO @AACR @kaelin_lab @DrJulieVose @DrMhidalgo @EJonasch So exciting! A memorable experience for so many.

First in-person @asco @aacr Vail Workshop in 3 years is off to a great start. Great talk last night @kaelin_lab reminding us to be rigorous, ask the right questions, use the right disease model, design trials that can quickly identify and advance drugs that work. #MCCR22

@jdegregori1 @CUCancerCenter Aww Thanks- we have much to learn about how older adults with cancer, and their care team, make treatment decisions

@simon_p_kim @TomFlaigMD @ASCOCancerLinQ @gershmanMD @bkonety What a great team!

@PalamaraMcgrath @colinjoyproject Love! Riley is checking and double-checking her “wish list”

I am so excited that our @colinjoyproject online shop has launched! We’ve been talking about this for years and now it’s finally here! For all of you who have asked how you can get your Colin’s Joy Project merch - now you can! colinsjoyproject.org/shop

Care planning priorities of older patients with advanced bladder cancer geriatriconcology.net/article/S1879-… @kesslerer @WilliamDale_MD @rochgerionc @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #AdvancedBladderCancer #CarePlanning #Qualitative

Check out the thickened liquid challenge! youtu.be/hN2Op6tcFQ4